研究单位:[1]Chinese Academy of Medical Sciences[2]Shanxi Province Cancer Hospital[3]Beijing Tongren Hospital[4]Fujian Medical University Union Hospital
研究目的:
The current study is a phase II multi-center single arm trial to evaluate the efficacy and safety of low-dose radiotherapy (3 Gy*4f) in indolent lymphoma.